The past year saw progress in acute treatment of ischaemic stroke, but large inequalities in stroke services were revealed, warranting strategical initiatives to improve treatment access. Reclassification of stroke as a disease of the nervous system in the WHO International Classification of Diseases 11th revision is likely to help such initiatives.
Key advances
-
Trials have confirmed that thrombectomy beyond 6 h and up to 24 h since stroke onset substantially benefits patients with large vessel occlusion and salvageable brain tissue1,2.
-
A mismatch of MRI findings in patients with wake-up stroke was shown to identify patients whose stroke onset was probably <4.5 h earlier and who could benefit from thrombolysis3.
-
Substantial inequalities in stroke services between and within countries were revealed; in Europe, research priorities and targets in stroke between 2018 and 2030 have been set8.
-
In the newly released WHO International Classification of Diseases 11th revision, stroke and all cerebrovascular diseases are placed under Diseases of the Nervous System with definitions for global use of the different codes10.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Neuronal extracellular vesicle derived miR-98 prevents salvageable neurons from microglial phagocytosis in acute ischemic stroke
Cell Death & Disease Open Access 06 January 2021
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Nogueira, R. G. et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N. Engl. J. Med. 378, 11–21 (2018).
Albers, G. W. et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N. Engl. J. Med. 378, 708–718 (2018).
Thomalla, G. et al. MRI-guided thrombolysis for stroke with unknown time of onset. N. Engl. J. Med. 379, 611–622 (2018).
Hemphill, J. C. III et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 7, 2032–2060 (2015).
Sprigg, N. Tranexamic acid for hyperacute primary intracerebral haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial. Lancet 391, 2107–2115 (2018).
Al-Shahi Salman, R. et al. Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data. Lancet Neurol. 17, 885–894 (2018).
Aguiar de Sousa, D. et al. Access to and delivery of acute ischaemic stroke treatments: a survey of national scientific societies and stroke experts in 44 European countries. Eur. Stroke J. https://doi.org/10.1177/2396987318786023 (2018).
Norrving, B. et al. Action plan for stroke in Europe 2018–2030. Eur. Stroke J. 3, 309–336 (2018).
Lindsay, P. et al. World Stroke Organization global stroke services guidelines and action plan. Int. J. Stroke 9 (Suppl. A100), 4–13 (2014).
[No authors listed.] ICD-11: a brave attempt at classifying a new world. Lancet 391, 2476 (2018).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author has received honoraria from AstraZeneca and from Bayer for Data Safety Monitoring Board work in the SOCRATES, THALES and NAVIGATE-ESUS trials. He is also editor-in-chief for the European Stroke Journal.
Rights and permissions
About this article
Cite this article
Norrving, B. Stroke management — recent advances and residual challenges. Nat Rev Neurol 15, 69–71 (2019). https://doi.org/10.1038/s41582-018-0129-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41582-018-0129-1
This article is cited by
-
Neuronal extracellular vesicle derived miR-98 prevents salvageable neurons from microglial phagocytosis in acute ischemic stroke
Cell Death & Disease (2021)
-
Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing
Nature Reviews Drug Discovery (2020)